Search

everythinglearnresearchcommunity

for

Search:↓

Removing a specific gene in certain skin cells causes hair loss on the body by disrupting normal hair development.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Substance from human umbilical cord blood cells promotes hair growth.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Procyanidin compounds from apples and barley promote hair growth and prevent hair cell death.

Blocking interferon-gamma might help treat various autoimmune diseases.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Women with PCOS may have a higher risk of Alzheimer's disease.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Too much β-catenin activity can mess up the development of mammary glands and make them more like hair follicles.